Related Experiment Video

Updated: Aug 19, 2026

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

Survival in congestive heart failure: have we made a difference?

B G Firth1, C W Yancy

  • 1Division of Cardiology, University of Texas Southwestern Medical Center, Dallas 75235-9034.

The American Journal of Medicine
|January 1, 1990
PubMed

Insights

Congestive heart failure (CHF) has a high mortality rate despite traditional treatments. New vasodilator therapies show promise but early intervention is key for improving survival in heart failure patients.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Congestive heart failure (CHF) impacts 400,000 new US patients annually, with over 50% mortality within five years.
  • The aging population exacerbates CHF prevalence, while surgical options like heart transplantation remain limited.
  • Traditional therapies (digitalis, diuretics) are insufficient for improving long-term survival in severe CHF.

Purpose of the Study:

  • To evaluate the efficacy of alternative medical therapies for congestive heart failure.
  • To explore vasodilator therapy as an addition or substitute for traditional CHF treatments.
  • To emphasize the importance of preventing left ventricular remodeling for improved patient survival.

Main Methods:

  • Review of existing studies on vasodilator therapy in severe heart failure.
  • Analysis of survival data for patients receiving captopril, enalapril, or hydralazine/isosorbide dinitrate combinations.
  • Assessment of interventions targeting early-stage cardiac disease processes.

Main Results:

  • Vasodilator therapy (ACE inhibitors or hydralazine/isosorbide dinitrate) improves survival when added to digitalis and diuretics in severe CHF.
  • Despite these advancements, mortality rates remain high in advanced stages of the disease.
  • Focus is shifting towards preventing left ventricular dilatation and remodeling before overt CHF occurs.

Conclusions:

  • Effective alternative medical therapies, particularly vasodilators, are crucial for improving survival in congestive heart failure.
  • Early intervention and prevention of cardiac remodeling are essential for significantly impacting CHF mortality.
  • Further research into interrupting the disease process at earlier stages is necessary for major survival improvements.

More Related Videos

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...